Published in Sci Rep on September 29, 2014
Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management. World J Gastroenterol (2015) 0.82
Generation of integration-free induced hepatocyte-like cells from mouse fibroblasts. Sci Rep (2015) 0.78
New Tools in Experimental Cellular Therapy for the Treatment of Liver Diseases. Curr Transplant Rep (2015) 0.77
Efficacy of Fluidized Bed Bioartificial Liver in Treating Fulminant Hepatic Failure in Pigs: A Metabolomics Study. Sci Rep (2016) 0.76
Paracrine Effects of Bone Marrow Mononuclear Cells in Survival and Cytokine Expression after 90% Partial Hepatectomy. Stem Cells Int (2017) 0.75
Impaired liver regeneration is associated with reduced cyclin B1 in natural killer T cell-deficient mice. BMC Gastroenterol (2017) 0.75
Detection of hepatic maturation by Raman spectroscopy in mesenchymal stromal cells undergoing hepatic differentiation. Stem Cell Res Ther (2016) 0.75
Adipose-derived stromal cell in regenerative medicine: A review. World J Stem Cells (2017) 0.75
Early indicators of prognosis in fulminant hepatic failure. Gastroenterology (1989) 7.43
Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature (2003) 6.92
Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature (2011) 5.28
Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell (1993) 4.76
Acute liver failure: Summary of a workshop. Hepatology (2008) 3.49
Efficacy of a chronic disease management model for patients with chronic liver failure. Clin Gastroenterol Hepatol (2013) 3.09
The origin and liver repopulating capacity of murine oval cells. Proc Natl Acad Sci U S A (2003) 2.99
Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice. Genes Dev (1993) 2.95
Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology (2008) 2.31
Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J Exp Med (2000) 2.25
Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology (1995) 2.21
Direct reprogramming of human fibroblasts to functional and expandable hepatocytes. Cell Stem Cell (2014) 2.15
Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers. Gut (2006) 1.96
IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice. Hepatology (2007) 1.69
Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure. J Gastroenterol Hepatol (2008) 1.68
Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. Science (1976) 1.65
Human hepatocyte transplantation: current experience and future challenges. Nat Rev Gastroenterol Hepatol (2010) 1.52
Contribution of Fas ligand to T cell-mediated hepatic injury in mice. Gastroenterology (1997) 1.41
Reprogramming fibroblasts into bipotential hepatic stem cells by defined factors. Cell Stem Cell (2013) 1.28
Epidemiology of acute liver failure. Curr Gastroenterol Rep (2007) 1.27
Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer. J Biol Chem (2011) 1.26
Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis. Hepatology (1996) 1.25
Purification of fetal liver stem/progenitor cells containing all the repopulation potential for normal adult rat liver. Gastroenterology (2008) 1.21
Isolation of oval cells from Long-Evans Cinnamon rats and their transformation into hepatocytes in vivo in the rat liver. Hepatology (1997) 1.21
Repopulation efficiencies of adult hepatocytes, fetal liver progenitor cells, and embryonic stem cell-derived hepatic cells in albumin-promoter-enhancer urokinase-type plasminogen activator mice. Am J Pathol (2009) 1.18
Principles of therapeutic liver repopulation. J Inherit Metab Dis (2006) 1.10
Liver support strategies: cutting-edge technologies. Nat Rev Gastroenterol Hepatol (2013) 1.04
Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell-mediated immunosuppression in mammalian species. Cell Death Differ (2013) 0.99
Immunosuppressive effect of bone marrow-derived mesenchymal stem cells in inflammatory microenvironment favours the growth of B16 melanoma cells. J Cell Mol Med (2011) 0.98
Concanavalin A-induced liver injury triggers hepatocyte proliferation. J Clin Invest (1998) 0.98
Integration and proliferation of transplanted cells in hepatic parenchyma following D-galactosamine-induced acute injury in F344 rats. J Pathol (2000) 0.97
Efficacy of adipose tissue-mesenchymal stem cell transplantation in rats with acetaminophen liver injury. Stem Cell Res (2013) 0.97
Critical role of interleukin 5 and eosinophils in concanavalin A-induced hepatitis in mice. Gastroenterology (2002) 0.96
Therapeutic potential of transplanted placental mesenchymal stem cells in treating Chinese miniature pigs with acute liver failure. BMC Med (2012) 0.93
Activation of toll-like receptor 3 attenuates alcoholic liver injury by stimulating Kupffer cells and stellate cells to produce interleukin-10 in mice. J Hepatol (2012) 0.92
Parenchymal expression of CD40 exacerbates adenovirus-induced hepatitis in mice. Hepatology (2011) 0.89
The regulation of T-cell recruitment to the human liver during acute liver failure. Liver Int (2013) 0.88
Comparative study of transplantation of hepatocytes at various differentiation stages into mice with lethal liver damage. Cell Transplant (2012) 0.86
Experimental transplantation of hepatocytes in cases of toxic acute liver failure. An allograft model. Transpl Int (1994) 0.84
Application of liver stem cells for cell therapy. Semin Cell Dev Biol (2007) 0.82